Abacavir Sulfate (188062-50-2): A Detailed Overview

Abacavir Sulfate (CAS number 188062-50-2) is a significant drug primarily utilized in the treatment of HIV disease and related additional illnesses . It functions as a nucleoside-like blocker , interfering with the viral replication process . Administered frequently in conjunction other AIDS drugs , abacavir provides a vital role in reducing the am

read more

Abacavir Sulfate: CAS Registry Number 188062-50-2

Abacavir sulfate, chemically defined as CAS number 188062-50-2, serves as a powerful HIV medication. It suppresses the replication of the human immunodeficiency virus (HIV) by interfering with the viral enzyme reverse transcriptase. This enzyme is crucial in the HIV life cycle, facilitating the virus to insert its genetic material into the host's D

read more

Pharmacological Properties of Abacavir Sulfate (188062-50-2)

Abacavir sulfate serves as a nucleoside reverse transcriptase inhibitor administered in the management of human immunodeficiency virus syndrome. Its pharmacological properties involve the selective inhibition of reverse transcriptase, an enzyme vital for HIV replication. Abacavir sulfate is a metabolite that undergoes transformation to its active

read more

Leading API Manufacturer & Supplier

In today's rapidly evolving technological landscape, reliable and high-performance APIs are essential for businesses of all sizes. The premier global API manufacturer and supplier delivers a comprehensive portfolio of cutting-edge APIs designed to meet the diverse needs of modern applications. With a unwavering commitment to quality, innovation, an

read more

Pharmacological Properties of Abacavir Sulfate (188062-50-2)

Abacavir sulfate acts as a nucleoside reverse transcriptase inhibitor administered in the management of human immunodeficiency virus disease. Its therapeutic properties stem from the selective inhibition of reverse transcriptase, an enzyme essential for HIV replication. Abacavir sulfate is a metabolite that transits transformation to its active fo

read more